US 9452182
Collateral gene inactivation biomarkers and targets for cancer therapy
granted A61KA61K31/191A61K31/198
Quick answer
US patent 9452182 (Collateral gene inactivation biomarkers and targets for cancer therapy) held by The Board of Regents of the University of Texas System expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/191, A61K31/198, A61K31/35, A61K31/352